Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica

Condition:   Polymyalgia Rheumatica Intervention:   Drug: Interleukin-2 Sponsor:   Peking University People's Hospital Not yet recruiting

Source: ClinicalTrials.gov - August 20, 2019 Category: Research Source Type: clinical trials